钢笔尖
发表于 2025-3-28 15:03:56
http://reply.papertrans.cn/16/1585/158487/158487_41.png
不真
发表于 2025-3-28 22:25:11
http://reply.papertrans.cn/16/1585/158487/158487_42.png
情感脆弱
发表于 2025-3-28 23:46:28
http://reply.papertrans.cn/16/1585/158487/158487_43.png
OVER
发表于 2025-3-29 04:45:45
Beverly A. Teicher (Vice President and Director ofIncludes supplementary material:
Harridan
发表于 2025-3-29 09:13:48
http://reply.papertrans.cn/16/1585/158487/158487_45.png
GRAVE
发表于 2025-3-29 14:41:12
http://reply.papertrans.cn/16/1585/158487/158487_46.png
semiskilled
发表于 2025-3-29 18:21:56
https://doi.org/10.1007/978-1-59259-739-0cancer; cell; clinical trial; drug; drug development; drug discovery; leukemia; research; screening; tumor
Detain
发表于 2025-3-29 22:44:03
http://reply.papertrans.cn/16/1585/158487/158487_48.png
一起平行
发表于 2025-3-30 00:16:10
https://doi.org/10.1007/978-3-540-34049-2The classic question in the field of drug discovery is: Which tumor model is a satisfactory predictor for cancer in humans? The classic answer is: None of them!
pineal-gland
发表于 2025-3-30 04:02:53
In Vivo Methods for Screening and Preclinical TestingThe classic question in the field of drug discovery is: Which tumor model is a satisfactory predictor for cancer in humans? The classic answer is: None of them!